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European Bat Lyssavirus 
Infection in Spanish 
Bat Populations 
Jordi Serra-Cobo,* Blanca Amengual,† Carlos Abellán,‡ and Hervé Bourhy†
From 1992 to 2000, 976 sera, 27 blood pellets, and 91 brains were obtained from 14 bat species in 37
localities in Spain. Specific anti-European bat lyssavirus 1 (EBL1)-neutralizing antibodies have been
detected in Myotis myotis, Miniopterus schreibersii, Tadarida teniotis, and Rhinolophus ferrumequinum in
the region of Aragon and the Balearic Islands. Positive results were also obtained by nested reverse tran-
scription-polymerase chain reaction on brain, blood pellet, lung, heart, tongue, and esophagus-larynx-
pharynx of M. myotis, Myotis nattereri, R. ferrumequinum, and M. schreibersii. Determination of nucleotide
sequence confirmed the presence of EBL1 RNA in the different tissues. In one colony, the prevalence of
seropositive bats over time corresponded to an asymmetrical curve, with a sudden initial increase peaking
at 60% of the bats, followed by a gradual decline. Banded seropositive bats were recovered during several
years, indicating that EBL1 infection in these bats was nonlethal. At least one of this species (M. schreiber-
sii) is migratory and thus could be partially responsible for the dissemination of EBL1 on both shores of the
Mediterranean Sea.
abies is a worldwide zoonosis due to Lyssavirus infec-
tion; multiple host species act as reservoirs. This disease
infects the central nervous system of humans and other mam-
mals. Bats are no exception, as proved by the 630 positive
cases detected in Europe from 1977 to 2000 (1,2). Recent
molecular studies have shown genetic differentiation in lys-
saviruses that cause rabies among European bats, leading to a
classification into two new genotypes, 5 and 6, which corre-
spond to European bat lyssavirus 1 (EBL1) and EBL2, respec-
tively (3,4). As a result of a recent molecular study, two new
lineages within genotype 5 have been identified—EBL1a and
EBL1b; the latter is potentially of African origin, which sug-
gests south-to-north transmission (5). However, despite molec-
ular advances and many European cases verified to date,
knowledge of the prevalence and epidemiology of EBL is lim-
ited. Of the 30 insectivorous bat species present in Europe,
approximately 95% of cases occur in the species Eptesicus
serotinus (2). This species, which is nonmigratory, cannot be
linked to all the different foci of positive cases in Europe (6).
In Spain, the first case of bat lyssaviruses was recorded in
1987 in Valencia. Sixteen more cases were reported in E.
serotinus (7). The distribution of positive cases in Spain is
indicated in Figure 1. 
Recently, clinically silent rabies infection has been
reported in zoo bats (Rousettus aegyptiacus) in Denmark and
the Netherlands (8). This observation, together with the results
of an experimental challenge, suggests that this frugivorous
bat species of African origin can survive EBL1 infection or
inoculation (9). Silent infection has also been described in the
American bat (Tadarida brasiliensis mexicana) (10,11) and
suggests an alternative viral strategy for Lyssavirus infection
of European insectivorous bats compared with the terminal
infection commonly associated with rabies infection. 
To investigate these observations, a 9-year study was
undertaken in Spain to locate and determine the colonies and
species of bats carrying EBL or Lyssavirus antibodies, monitor
the prevalence of seropositive bats, and characterize circulat-
ing lyssaviruses. 
Material and Methods
Selection of Bat Colonies and Banding
The study area consisted mainly of the Spanish Autono-
mous Regions of Aragon, Balearic Islands, Catalonia, and
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Figure 1. Map showing the localities in Spain where bats have been
analyzed. 1. Ciutadella; 2. El Saler; 3. Ferreries; 4. Inca; 5. Llucmajor;
6. Oliete; 7. Pollença; 8. Granada; 9. Huelva; 10. Sevilla. Points in red
indicate colonies where positive results were obtained according to our
study (Localities Nos. 1, 3, 4, 5, 6, and 7) and previous studies (Locali-
ties Nos. 2, 8, 9, and 10) (7).RESEARCH
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Valencia (Figure 1) (12-15). The region of Ceuta (North
Africa, near the Straits of Gibraltar) was also studied because
of its proximity to Europe. Bat colonies were selected accord-
ing to the following criteria: colony behavior (anthropophilic,
migratory, gregarious) and proximity of the colonies to urban
areas. The Valencia bat colony was widely sampled because
the first case of bat Lyssavirus in Spain was reported there (7).
Colonies exhibiting positive sera were more intensively
explored during the years after the first detection. From 1996
to 2000, bats from the locations Nos. 4, 5, and 7 were banded
in the forearm to facilitate monitoring of their movements
between colonies (16). 
Blood Sampling 
To draw blood, we set the bat face upward with a stretched
wing. The patagium was wiped clean and locally disinfected
with a sanitary towel soaked in 96% alcohol to prevent infec-
tions. Immediately afterwards, a small puncture was made
next to the radius proximal epiphysis. Blood was collected in
an Eppendorf vial by using a Pasteur pipette. The amount of
blood sampled varied from 0.2 mL to 0.5 mL, according to the
size of the animal. A sterilized absorbent hemostatic sponge
impregnated with gelatin was administered to prevent bleeding
and facilitate healing. Pressure was applied to the wound with
a sanitary towel for 30 seconds. The bats were given 10% glu-
cose water to drink to prevent dehydration and provide rapidly
assimilated compounds for energy. Once bleeding ceased, the
bat was released. Vials containing blood were stored at 4ºC for
a few hours. Samples were centrifuged for 20 minutes at 5,000
rpm, and the serum was extracted with a pipette. Serum sam-
ples and blood pellets were stored at –20°C. 
Detection of EBL Antibodies
The technique used for the detection of EBL antibodies is
an adaptation of the Rapid Fluorescent Focus Inhibition Test
(17). A constant dose of a previously titrated, cell culture-
adapted EBL1 challenge virus 8918FRA (5) was incubated
with threefold dilutions of the sera to be titrated. After incuba-
tion of the serum/virus mixtures, a suspension of BSR (a clone
of BHK-21) cells was added. After 24 hours’ incubation, the
cell monolayer was acetone-fixed and stained with a fluores-
cent anti-nucleocapsid antibody (Bio-Rad, Marnes-la-
Coquette, France) to detect the presence of non-neutralized
virus (fluorescent foci). Titers are presented as an arithmetic
mean of two independent repetitions. Serum samples with
antibody titers <27 are considered negative for EBL1-neutral-
izing antibodies. The percentages of seropositive bats and the
years in which bats were analyzed (from 1996 to 2000) were
correlated, and regression curves were obtained. To confirm
the specificity of the reaction, the same test was performed on
selected sera by using the challenge virus strain (CVS) (17)
and 9007FIN EBL2 challenge viruses (5).
Brain Sampling
Brain samples were obtained from dead bats, submitted by
citizens. Dead bats found in the studied refuges were also
gathered. The bats found dead from 1994 to 1996 were ana-
lyzed by direct immunofluorescence technique (17,18). The
bats found dead from 1997 to 2000 were analyzed by nested
reverse transcription-polymerase chain reaction (RT-PCR) (9).
To eliminate cross-contamination at necropsy, sterilized instru-
ments were used.
Detection of EBL Antigens 
The standard fluorescent antibody test (FAT) was per-
formed on brain tissue specimens of the bats by using the poly-
clonal fluorescein isothiocyanate-labeled rabbit anti-rabies
nucleocapsid immunoglobulin G, as described by the manufac-
turer (Bio-Rad). Brain smears obtained from noninfected and
CVS-infected mice were incorporated as controls in each FAT
test run. 
Detection of EBL1 RNA
Total RNA was extracted from tissue samples (50 mg -100
mg) by using the TRIzol method (Invitrogen, Groningen, the
Netherlands), purified with chloroform and precipitated with
iso-propanol (Merck, Darmstadt, Germany). After being
washed with 70% ethanol, the RNA pellet was dried, resus-
pended in a volume of 50 mL bidistilled water and stored at
–20ºC. cDNA synthesis of the genomic and antigenomic sense
of the EBL1a nucleoprotein RNA was performed by anneal-
ing, at 70ºC for 3 minutes, 2 mL of total RNA extract with 15
pmol of primers N60 (5'-TCCATAATCAGCTGGTCTCG-3',
positions 98-117, relative to rabies genome) (19) and N41, as
described previously (5).
Amplification of 5 mL of the cDNA template was per-
formed in a final volume of 50 mL containing 1x magnesium-
free PCR buffer (Invitrogen), 5 mM deoxynucleoside triphos-
phate (NTP) mix (containing 1.25 mM each of dATP, dCTP,
dGTP, and dTTP), 5 mM magnesium chloride (Invitrogen), 2
U Taq DNA polymerase (Invitrogen), and 30 pmol of primers
N60 and N41. The amplification was performed on a Gene-
Amp PCR System 9700 Thermal cycler. The program started
with one denaturation step at 94ºC for 5 minutes, followed by
30 cycles of 94ºC for 30 sec, 60ºC for 30 sec, and 72ºC for 40
sec. The amplification was finalized by an ultimate elongation
step at 72ºC for 5 min. The primary amplification products
were stored at –20ºC. For nested RT-PCR, the amplified prod-
uct was diluted 10 times in distilled water. Then the second
amplification was performed as described above with the fol-
lowing modifications: 30 pmol of primers N62 and N63 (N62:
5'-AAACCAAGCATCACTCTCGG-3', position 181-200;
N63: 5'-ACTAGTCCAATCTTCCGGGC-3', position 342-323
relative to the Rabies virus genome) (19) were used, and the
elongation steps were performed at 72ºC for 30 sec. Aliquots
(5 µL) of nRT-PCR products were analyzed by horizontal aga-
rose (1.5%) gel electrophoresis. Gels were stained with 1 µg/
mL ethidium bromide and photographed under UV light.
Extraction of RNA was performed in a level-2 biosafety
laboratory. Then we prepared the template and RT-PCR mixEmerging Infectious Diseases  •  Vol. 8, No. 4, April 2002 415
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and added DNA to the mix with aerosol-resistant tips in two
different rooms. We also performed nRT-PCR on tissue RNA,
omitting reverse transcriptase. Positive (isolate no. 2002FRA)
and negative (H2O) controls were incorporated into each of the
following steps: total RNA extraction, cDNA synthesis, and
each of the two steps of the amplification program. To avoid
false-positive results, usual precautions for PCR were strictly
followed in the laboratory (20,21). 
The threshold of detection of the nRT-PCR method was
determined by preparing 10-fold dilutions of a pretitrated sus-
pension of Strain 8918FRA (4) in TRIzol (GIBCO-BRL).
Total RNA extraction, cDNA synthesis, and the RT-PCR pro-
cedures were performed as described above. 
Sequencing of amplified products was performed by using
the primers N62 and N63 and an Applied Biosystems 373A
sequencer (Foster City, CA), according to the Applied Biosys-
tems protocol. Multiple sequence alignments were generated
with the Clustal W 1.60 program (22).
Results
Presence of EBL1 Antibodies in Six Bat Colonies
We describe here a very efficient technique of blood col-
lection, which is more humane than collection by cardiac
puncture (23,24). The bats recaptured 1 week after the blood
extraction did not show any trace of a scar. Furthermore, our
technique is easier than collection by puncture of the uropat-
agium or the propatagium cardiac veins (25). To eliminate any
false- or doubtful positive reactions in seroneutralization, the
threshold of positivity (titer=27) was chosen higher than the
one adopted by other authors (24). Two independent repeti-
tions of the seroneutralization also reinforced the accuracy of
our results.
Throughout the 9-year study, 976 sera obtained from 14
bat species in 37 different locations were analyzed (Table 1);
76 (7.8%) were positive (Table 2). Lyssavirus antibodies were
detected in four bat species (Myotis myotis,  Miniopterus
schreibersii, Tadarida teniotis, and Rhinolophus ferrumequi-
num). Sixteen positive sera and 5 negative sera against EBL1
(genotype 5 of lyssaviruses) were further tested against stan-
dard strains of genotypes 1 (CVS), and 6 (EBL2). These sera
were obtained from the four EBL1-seropositive bat species
and from another bat species that remained negative (R. eury-
ale). None of them reacted positively against CVS and EBL2,
confirming the specificity of the positive reactions against
EBL1 obtained in these species (Table 3).
The highest percentages of seropositive bats, 22.7% and
20.8%, were observed in the Balearic Islands in the locations
of Inca (No. 4) and Llucmajor (No. 5), respectively (Table 2).
From spring to autumn, location No. 4 shelters a plurispecific
colony of approximately 1,000 bats belonging to the following
species: M. myotis (25% of seropositives), M. schreibersii, R.
ferrumequinum, M. capaccinii, and M. nattereri. At the begin-
ning of summer, M. myotis, M. nattereri, and M. schreibersii
species form breeding pairs. Location No. 5 shelters a sum-
mer-breeding colony of approximately 500 bats of the species
M. myotis (22.5% of seropositives), M. schreibersii (7.1% of
seropositives), and M. capaccinii. In both sites the most abun-
dant species is M. myotis. 
Seropositive bats were also found in four other locations,
Nos. 1, 3, 6, and 7. Location No. 1 (5.5% of seropositive R. fer-
rumequinum) shelters a breeding colony of R. ferrumequinum.
Table 1. Number of bat samples analyzed per species, 1992–2000a
Species 1992 1993 1994 1995 1996 1997 1998 1999 2000 Total
R. ferrumequinum 8 9/3 11/1 30/3 58/7
R. euryale 61 0 1 6
R. hipposideros 16 0/1 16/1
P. pipistrellus 61 64 75 18 13/5 0/16 0/14 3/15 234/50
P. kulhii 11
E. serotinus 21 44 33/1 1 99/1
M. myotis 1 63 65/2 44 29/2 58/8 35/3 295/15
M. blythi 20 1 2 23
M. nattereri 1 0/1 0/1 1/2
M. capaccinii 33
M. emarginatus 9 7/2 16/2
P. austriacus 3 6 2/4 1 12/4
Mi. schreibersii 8 18 14 8 9/2 70/6 41/1 168/9
T. teniotis 22 12 34
Total 90 118 123 148/1 127/11 83/22 38/19 143/30 106/8 976/91
aWhere fractions (x/y) are shown, the numerator (x) corresponds to the number of sera analyzed and the denominator (y) to the number of brains analyzed.
E = Eptesicus; M = Myotis; Mi=Miniopterus P = Plecotus; R = Rhinolophus; T = Tadarida.RESEARCH
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In spring, the colony also includes some M. schreibersii. Loca-
tion No. 3 (2.9% of seropositive M. schreibersii) is a hiberna-
tion refuge for approximately 2,200 M. schreibersii; some M.
capaccinii are also present. Location No. 6 (5.8% of seroposi-
tive T. teniotis) is a big sinkhole with a resident bat colony
belonging to the following species: T. teniotis, M. blythii, M.
daubentonii, Pipistrellus pipistrellus, Pipistrellus kuhlii, Hyp-
sugo savii, E. serotinus, Plecotus austriacus, and Barbastella
barbastellus (26). Location No. 7 (12% of seropositive M.
schreibersii) shelters a colony of M. schreibersii, M. capacci-
nii, and M. myotis.
Evolution of the Percentage of Seropositive 
Bats in Colonies Nos. 4 and 5
In Location 4, the percentage of seropositive bats rose
from 3.3% in 1995 to 59.3% in 1996 (Table 2). Then it
decreased significantly (Y=-15.6X + 31,196.5, r=-0.989,
p<0.05) until 1999, when it reached 10%. This percentage
remained stable in 2000. The percentage of seropositive bats
remained stable in Location No. 5 from 1995 to 2000.
Exchange of Animals Between Colonies 
and Survival of Seropositive Bats
During the period 1996-2000, 355 and 87 M. myotis were
banded in Locations Nos. 4 and 5, respectively (Table 4).
Recapture of the banded M. myotis allowed us to prove a few
exchange of bats between the colonies. Two percent of M.
myotis banded in Location No. 5 moved to Location No. 4 (the
refuges are about 35 km apart). During the same period, 13
and 33 M. schreibersii were banded in Locations Nos. 5 and 7,
respectively. One of the 33 M. schreibersii moved to Location
No. 5 (the refuges are approximately 47 km apart); another
moved to Location No. 4 (a distance of 11 km) (Figure 1). 
Banding also allowed us to follow the seroneutralization
titer of some bats during the study period. The serum of a M.
schreibersii captured in Location No. 7 in 1996 was negative;
Table 2. Positive serologic results in bat populations, the Spanish Autonomous Regions of Balearic Islands and Aragon, 1995–2000
Location and coordinates Variables analyzed
Years
1995 1996 1997 1998 1999 2000
No. 1 A/Ba - - 1/5 - 0/11 1/20
X±SDb -- 5 1 5 - - 3 4
39°58’N,3°58’E Speciesc Rf Rf Rf Rf Rf Rf
No. 3 A/Ba 1/34 0/31
X±SDb 215
39°58’N,3°59’E Speciesc Ms Ms Ms Ms Ms Ms
No. 4 A/Ba 1/30 16/27 11/27 7/22 3/30 3/29
X±SDb 90 348±237 191±225 718±657 78±27 58±42
39°44’N,2°58’E Range 49–908 29-783 79-1677 47-95 29–107
Speciesc Mm Mm Mm Mm Mm Mm
No. 5 A/Ba 7/21 7/32 3/17 0/6 3/7 1/8 5/28 0/6
X±SDb 122±45 207±159 218±136 412±454 8,508 106±61
39°25’N,2°55’E Range 83-195 53-442 129-374 87-930 29-176
Speciesc Mm Mm Mm Ms Mm Ms Mm Mm
No. 6 A/Ba 0/22 2/12
X±SDb 243±284
41°01’N,0°39’W Range 420-444
Speciesc Tt Tt Tt Tt Tt Tt
No. 7 A/Ba 2/14 2/19
X±SDb 93±68 35±6
39°50’N,3°00’E Range 45-141 31-40
Speciesc Ms Ms Ms Ms Ms Ms
aA = no. bats positive, B = no. bats analyzed.
bX = seroneutralization average; SD = standard deviation.
cSpecies analyzed: Rf = Rhinolophus ferrumequinum; Ms = Miniopterus schreibersii; Mm = Myotis myotis; Tt = Tadarida teniotis.Emerging Infectious Diseases  •  Vol. 8, No. 4, April 2002 417
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another serologic sample obtained from the same bat 2 years
later in Location No. 5 yielded a titer of 8,508. During spring
2000, 12 M. myotis previously banded and analyzed were
recaptured in Location No. 4. Four (33%) of them had already
been shown to be seropositive in preceding years: two in sum-
mer 1997 (titers 29 and 145, respectively), one in summer
1998 (titer 303), and one in summer 1999 (titer 95). This indi-
cates that some seropositive bats may survive at least 3 years
after Lyssavirus infection. 
Detection and Characterization of EBL1 RNA in Bats
During 1995 through 1996, 12 brain samples were only
analyzed by FAT. After 1996, the brain samples (n=79) were
also analyzed by nested RT-PCR (Table 1). All brains (n=91)
analyzed by FAT were negative. In contrast, brains of 1 M.
myotis, 1 M. nattereri, and 1 M. schreibersii (No. 140) of
Location No. 4 and 1 R. ferrumequinum (No. 128) of Location
No. 1 (all collected in 2000) were positive by nested RT-PCR.
Four animals (M. schreibersii [No. 140] and R. ferrumequinum
[No. 128], whose brains were positive by nested RT-PCR, and
two R. ferrumequinum [No. 123 and No. 135], whose brains
were negative) were completely necropsied. Various organs
and tissues (medulla, liver, kidney, spleen, heart, tongue,
esophagus-larynx-pharynx, and lung) were collected and sub-
jected to nRT-PCR. Esophagus-larynx-pharynx and lung of bat
No. 135 and tongue, lung, and heart of bat No. 128 were posi-
tive (Figure 2).
Twenty-seven blood pellets of bats collected in 2000 were
also analyzed by nRT-PCR. These samples were obtained from
8  R. ferrumequinum (location No. 1), 1 R. ferrumequinum
(Location No. 3), 1 M. myotis (Location No. 5), 14 M. myotis
(Location No. 4), and 3 M. schreibersii (Location No. 4). The
blood pellets of three M. myotis from Location No. 4 were
found positive by nRT-PCR. None of the blood samples show-
ing positive RT-PCR results on the pellet were found positive
by seroneutralization. 
The threshold of detection of the nRT-PCR for the amplifi-
cation of the EBL1a genomic and antigenomic RNAs of the N
gene was 5 x 10-2 fluorescent forming units of EBL1a/mL. In
all these experiments, negative controls performed individu-
ally for each step (extraction, RT, primary, and secondary
PCR) were negative. Furthermore, nRT-PCR performed on
positive tissues without previous reverse transcription gave
negative results, demonstrating the absence of complementary
DNA contamination.
Nucleotide (nt) sequences were determined by using the
positive nRT-PCR products obtained from the four brains and
from one blood sample. These 122-nt long sequences of the
nucleoprotein gene were strictly similar to the sequence of two
EBL1b Spanish isolates (94285SPA and 9483 SPA) described
previously (5), except that the sequence obtained from the pos-
itive blood pellet exhibited a TJA mutation in position 145
of the coding region of the nucleoprotein gene. Four mutations
distinguished the sequence of the positive control correspond-
ing to a French bat (No. 2002FRA) from the different
sequences obtained from Spanish bats (not shown). This fur-
ther confirms the specificity of the products amplified from the
Spanish bat samples.
Discussion
This is the first report of the presence of EBL1-specific neu-
tralizing antibodies in four European insectivorous bat species
(M. myotis,  M. schreibersii, T. teniotis, and  R. ferrumequi-
num). These findings lead to the following observations on the
circulation and possible bat species involved in the dispersion
of EBL1 in southern Europe. First, the identification of EBL1
antibodies in 24% of the M. myotis analyzed in Locations No.
4 and No. 5 in 1995 through 2000 (n=276) indicates that bats
of this genus are infected with EBL1. Second, the distribution
of T. teniotis and M. schreibersii in southern Europe and north-
ern Africa (13,27) could contribute to the dispersion of EBL1
in southern Europe and is concordant with the possible African
origin of EBL1, as suggested by Amengual et al. (5).
Although the seasonal movements of T. teniotis are
scarcely known, the quick, straight flight of this species
Table 3. Specificity of results from serologic studies of bat popula-
tions, Spanish Autonomous Regions of Balearic Islands and Aragon, 
1995–2000a
Location Species CVS EBL1 EBL2






























































Rhinolophus euryale 0< 2 7 < 2 7
aND = not done; CVS = challenge virus strain; EBL1 = European bat lys-
savirus 1.
Table 4. No. of recaptured and analyzed bats in Locations 4, 5, and 7, 
Spain, 1996–2000
Speciesa BBb BAc BRd BRDe ATTf
Mm 442 221 25 2 4
Ms 46 46 0 2 1
aSpecies studied: Mm = Myotis myotis; Ms = Miniopterus schreibersii.
bBB = No.of bats banded.
cBA = No. of bats banded and analyzed.
dBR = No. of bats banded and recaptured in the same location.
eBRD = No. of bats banded and recaptured in different localities.
fATT = No. of bats analyzed twice at interval of  >1 year.RESEARCH
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suggests that such movements are long, as is the case with the
American bat (T. brasiliensis mexicana), which is capable of
performing annual migrations of more than 1,000 km. Since
M. schreibersii makes seasonal migrations (some of them
>350 km) (16), this species could also be one of the dispersion
vectors of the disease in southern Europe, where it abounds.
M. schreibersii dwells in five out of the six sites where seropos-
itive bats have been found. In three of them, M. schreibersii
forms mixed colonies with M. myotis, in one it shelters next to
R. ferrumequinum, and in the fifth it shelters alone. M.
schreibersii and M. myotis have direct physical contact in the
mixed colonies.  However, it is unlikely that Pipistrellus
nathusii is a dispersion vector of the lyssaviruses in Spain, as
Brosset (6) suggests, since this is a very rare bat in the Iberian
Peninsula.
The results obtained in 1995-2000 in Location No. 4 show
that the evolution in the number of seropositive bats after a
Lyssavirus infection corresponded to an asymmetrical curve,
with a sudden initial increase reaching more than 60% of the
colony and a gradual decline over subsequent years (24)—
unless a new episode took place (Figure 3). Because of the gre-
garious behavior of this species, a quick increase and a high
seropositive percentage (almost 60% in this location) after a
Lyssavirus episode are not unusual. The intimate contact that
always exists among bats must facilitate viral transmission and
antibody development. A high seropositive percentage also
occurs in colonies of T. brasiliensis mexicana, where percent-
ages >80% have been observed (10,11). The transmission of
lyssaviruses between bats from mixed colonies could take
place through breathing or biting but is currently not
documented. 
The low prevalence (0 of 91, <1.1%) of active infection as
determined by FAT is concordant with previous results
obtained in America, which show a prevalence of active rabies
infection in bats between 0.1 and 2.9% (10,28,29). However,
we report the first detection of EBL1 RNA by nRT-PCR in
several tissues (brain, blood pellet, lung, heart, tongue, and
esophagus-larynx-pharynx) of four M. myotis, one M. nattereri,
one M. schreibersii, and two R. ferrumequinum. These isolates
show the existence of a low or nonproductive infection in these
species, although some small remnant of RNA remaining in a
clinically normal bat as a result of an earlier nonlethal exposure
to a Lyssavirus is also possible. This low amount of viral DNA
present in the tissues underscores the need to use nRT-PCR as a
very sensitive technique for epidemiologic studies of EBL1 in
bat populations. Rønsholt et al. (8) also comment on the diffi-
culty of detecting Lyssavirus infection by immunofluorescence
in bats when a clinically silent infection exists. 
EBL1 are known to actively infect the brain, lung, and
tongue of E. serotinus (3). However, this is the first report that
EBL1 RNA can be detected in various organs and tissues in
the absence of active infection, as demonstrated by negative
results obtained by FAT. Most of these bats were dead when
collected but were kept in conditions that allowed the classic
diagnosis by FAT to be performed properly. These negative
FAT results indicate that these bats died of causes other than
their low productive Lyssavirus infection. The recapture of
seropositive bats over several years also shows that some of
these bats survived EBL1 infection. The detection of EBL1b
sequences in the blood pellet of bats (3/27) is also a new find-
ing. This technique would be an easy test for screening posi-
tive bats. However, further studies are needed to establish the
interest and sensitivity of this sample. 
The sensitivity of the different European bat species to
EBL infection probably varies according to the animal and
virus species involved. Therefore, we have summarized in
Figure 3. Incidence of seropositive bats observed in Myotis myotis col-
onies, Spanish Locations No. 4 and No. 5, 1995–2000 (95% confi-
dence intervals shown).
Figure 2. Detection of European bat Lyssavirus 1 RNA in bats by nested reverse transcription-polymerase chain reaction (PCR). Lanes: 1, brain of
Miniopterus schreibersii No. 140; 2- 5, medulla, tongue, esophagus-larynx-pharynx, and lung of Rhinolophus ferrumequinum No. 135, respectively;
6-14, brain, medulla, esophagus-larynx-pharynx, liver, lung, heart, tongue, spleen, and kidney of R. ferrumequinum No. 128, respectively; 15, neg-
ative control of RNA extraction of bat No. 135; 16, negative control of RNA extraction of bat No. 128; 17, negative control of RNA extraction of bat
No. 140; 18, positive control; 19, negative control of first PCR; 20, negative control of second PCR.Emerging Infectious Diseases  •  Vol. 8, No. 4, April 2002 419
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Table 5 (2,5,24,30,31) the bat species in which either Lyssavi-
rus or antibodies against Lyssavirus have been detected. Fur-
ther studies are needed to determine which of the European bat
species are the reservoir of EBL infection and if different spe-
cies act as sentinels for the presence of the virus in the colony.
The presence of EBL1 RNA and immunity to EBL1 in
several wild bat colonies also has important implications for
bat management and public health. The probability of humans’
having contact with these colonies should be reduced and con-
trolled. In our study, most bat colonies were found in sites that
are frequently visited by speleologists, tourists, and bat-lovers.
As a consequence of our findings, the entry to these caves is
now controlled and limited during the periods when bats are
present (in spring, summer, and autumn for Location No. 4).
Entry is limited by horizontal bars that allow the bats to fly
across them but prevent access to people without obscuring the
view. 
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